Cargando…

Symptoms, SARS-CoV-2 Antibodies, and Neutralization Capacity in a Cross Sectional-Population of German Children

Background: Children and youth are affected rather mildly in the acute phase of COVID-19 and thus, SARS-CoV-2 infection infection may easily be overlooked. In the light of current discussions on the vaccinations of children it seems necessary to better identify children who are immune against SARS-C...

Descripción completa

Detalles Bibliográficos
Autores principales: Laub, Otto, Leipold, Georg, Toncheva, Antoaneta A., Peterhoff, David, Einhauser, Sebastian, Neckermann, Patrick, Borchers, Natascha, Santos-Valente, Elisangela, Kheiroddin, Parastoo, Buntrock-Döpke, Heike, Laub, Sarah, Schöberl, Patricia, Schweiger-Kabesch, Andrea, Ewald, Dominik, Horn, Michael, Niggel, Jakob, Ambrosch, Andreas, Überla, Klaus, Gerling, Stephan, Brandstetter, Susanne, Wagner, Ralf, Kabesch, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8522552/
https://www.ncbi.nlm.nih.gov/pubmed/34671582
http://dx.doi.org/10.3389/fped.2021.678937
_version_ 1784585110138388480
author Laub, Otto
Leipold, Georg
Toncheva, Antoaneta A.
Peterhoff, David
Einhauser, Sebastian
Neckermann, Patrick
Borchers, Natascha
Santos-Valente, Elisangela
Kheiroddin, Parastoo
Buntrock-Döpke, Heike
Laub, Sarah
Schöberl, Patricia
Schweiger-Kabesch, Andrea
Ewald, Dominik
Horn, Michael
Niggel, Jakob
Ambrosch, Andreas
Überla, Klaus
Gerling, Stephan
Brandstetter, Susanne
Wagner, Ralf
Kabesch, Michael
author_facet Laub, Otto
Leipold, Georg
Toncheva, Antoaneta A.
Peterhoff, David
Einhauser, Sebastian
Neckermann, Patrick
Borchers, Natascha
Santos-Valente, Elisangela
Kheiroddin, Parastoo
Buntrock-Döpke, Heike
Laub, Sarah
Schöberl, Patricia
Schweiger-Kabesch, Andrea
Ewald, Dominik
Horn, Michael
Niggel, Jakob
Ambrosch, Andreas
Überla, Klaus
Gerling, Stephan
Brandstetter, Susanne
Wagner, Ralf
Kabesch, Michael
author_sort Laub, Otto
collection PubMed
description Background: Children and youth are affected rather mildly in the acute phase of COVID-19 and thus, SARS-CoV-2 infection infection may easily be overlooked. In the light of current discussions on the vaccinations of children it seems necessary to better identify children who are immune against SARS-CoV-2 due to a previous infection and to better understand COVID-19 related immune reactions in children. Methods: In a cross-sectional design, children aged 1–17 were recruited through primary care pediatricians for the study (a) randomly, if they had an appointment for a regular health check-up or (b) if parents and children volunteered and actively wanted to participate in the study. Symptoms were recorded and two antibody tests were performed in parallel directed against S (in house test) and N (Roche Elecsys) viral proteins. In children with antibody response in either test, neutralization activity was determined. Results: We identified antibodies against SARS-CoV-2 in 162 of 2,832 eligible children (5.7%) between end of May and end of July 2020 in three, in part strongly affected regions of Bavaria in the first wave of the pandemic. Approximately 60% of antibody positive children (n = 97) showed high levels (>97th percentile) of antibodies against N-protein, and for the S-protein, similar results were found. Sufficient neutralizing activity was detected for only 135 antibody positive children (86%), irrespective of age and sex. Initial COVID-19 symptoms were unspecific in children except for the loss of smell and taste and unrelated to antibody responses or neutralization capacity. Approximately 30% of PCR positive children did not show seroconversion in our small subsample in which PCR tests were performed. Conclusions: Symptoms of SARS-CoV-2 infections are unspecific in children and antibody responses show a dichotomous structure with strong responses in many and no detectable antibodies in PCR positive children and missing neutralization activity in a relevant proportion of the young population.
format Online
Article
Text
id pubmed-8522552
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-85225522021-10-19 Symptoms, SARS-CoV-2 Antibodies, and Neutralization Capacity in a Cross Sectional-Population of German Children Laub, Otto Leipold, Georg Toncheva, Antoaneta A. Peterhoff, David Einhauser, Sebastian Neckermann, Patrick Borchers, Natascha Santos-Valente, Elisangela Kheiroddin, Parastoo Buntrock-Döpke, Heike Laub, Sarah Schöberl, Patricia Schweiger-Kabesch, Andrea Ewald, Dominik Horn, Michael Niggel, Jakob Ambrosch, Andreas Überla, Klaus Gerling, Stephan Brandstetter, Susanne Wagner, Ralf Kabesch, Michael Front Pediatr Pediatrics Background: Children and youth are affected rather mildly in the acute phase of COVID-19 and thus, SARS-CoV-2 infection infection may easily be overlooked. In the light of current discussions on the vaccinations of children it seems necessary to better identify children who are immune against SARS-CoV-2 due to a previous infection and to better understand COVID-19 related immune reactions in children. Methods: In a cross-sectional design, children aged 1–17 were recruited through primary care pediatricians for the study (a) randomly, if they had an appointment for a regular health check-up or (b) if parents and children volunteered and actively wanted to participate in the study. Symptoms were recorded and two antibody tests were performed in parallel directed against S (in house test) and N (Roche Elecsys) viral proteins. In children with antibody response in either test, neutralization activity was determined. Results: We identified antibodies against SARS-CoV-2 in 162 of 2,832 eligible children (5.7%) between end of May and end of July 2020 in three, in part strongly affected regions of Bavaria in the first wave of the pandemic. Approximately 60% of antibody positive children (n = 97) showed high levels (>97th percentile) of antibodies against N-protein, and for the S-protein, similar results were found. Sufficient neutralizing activity was detected for only 135 antibody positive children (86%), irrespective of age and sex. Initial COVID-19 symptoms were unspecific in children except for the loss of smell and taste and unrelated to antibody responses or neutralization capacity. Approximately 30% of PCR positive children did not show seroconversion in our small subsample in which PCR tests were performed. Conclusions: Symptoms of SARS-CoV-2 infections are unspecific in children and antibody responses show a dichotomous structure with strong responses in many and no detectable antibodies in PCR positive children and missing neutralization activity in a relevant proportion of the young population. Frontiers Media S.A. 2021-10-04 /pmc/articles/PMC8522552/ /pubmed/34671582 http://dx.doi.org/10.3389/fped.2021.678937 Text en Copyright © 2021 Laub, Leipold, Toncheva, Peterhoff, Einhauser, Neckermann, Borchers, Santos-Valente, Kheiroddin, Buntrock-Döpke, Laub, Schöberl, Schweiger-Kabesch, Ewald, Horn, Niggel, Ambrosch, Überla, Gerling, Brandstetter, Wagner, Kabesch and Corona Virus Antibodies in Children from Bavaria (CoKiBa) Study Group. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pediatrics
Laub, Otto
Leipold, Georg
Toncheva, Antoaneta A.
Peterhoff, David
Einhauser, Sebastian
Neckermann, Patrick
Borchers, Natascha
Santos-Valente, Elisangela
Kheiroddin, Parastoo
Buntrock-Döpke, Heike
Laub, Sarah
Schöberl, Patricia
Schweiger-Kabesch, Andrea
Ewald, Dominik
Horn, Michael
Niggel, Jakob
Ambrosch, Andreas
Überla, Klaus
Gerling, Stephan
Brandstetter, Susanne
Wagner, Ralf
Kabesch, Michael
Symptoms, SARS-CoV-2 Antibodies, and Neutralization Capacity in a Cross Sectional-Population of German Children
title Symptoms, SARS-CoV-2 Antibodies, and Neutralization Capacity in a Cross Sectional-Population of German Children
title_full Symptoms, SARS-CoV-2 Antibodies, and Neutralization Capacity in a Cross Sectional-Population of German Children
title_fullStr Symptoms, SARS-CoV-2 Antibodies, and Neutralization Capacity in a Cross Sectional-Population of German Children
title_full_unstemmed Symptoms, SARS-CoV-2 Antibodies, and Neutralization Capacity in a Cross Sectional-Population of German Children
title_short Symptoms, SARS-CoV-2 Antibodies, and Neutralization Capacity in a Cross Sectional-Population of German Children
title_sort symptoms, sars-cov-2 antibodies, and neutralization capacity in a cross sectional-population of german children
topic Pediatrics
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8522552/
https://www.ncbi.nlm.nih.gov/pubmed/34671582
http://dx.doi.org/10.3389/fped.2021.678937
work_keys_str_mv AT laubotto symptomssarscov2antibodiesandneutralizationcapacityinacrosssectionalpopulationofgermanchildren
AT leipoldgeorg symptomssarscov2antibodiesandneutralizationcapacityinacrosssectionalpopulationofgermanchildren
AT tonchevaantoanetaa symptomssarscov2antibodiesandneutralizationcapacityinacrosssectionalpopulationofgermanchildren
AT peterhoffdavid symptomssarscov2antibodiesandneutralizationcapacityinacrosssectionalpopulationofgermanchildren
AT einhausersebastian symptomssarscov2antibodiesandneutralizationcapacityinacrosssectionalpopulationofgermanchildren
AT neckermannpatrick symptomssarscov2antibodiesandneutralizationcapacityinacrosssectionalpopulationofgermanchildren
AT borchersnatascha symptomssarscov2antibodiesandneutralizationcapacityinacrosssectionalpopulationofgermanchildren
AT santosvalenteelisangela symptomssarscov2antibodiesandneutralizationcapacityinacrosssectionalpopulationofgermanchildren
AT kheiroddinparastoo symptomssarscov2antibodiesandneutralizationcapacityinacrosssectionalpopulationofgermanchildren
AT buntrockdopkeheike symptomssarscov2antibodiesandneutralizationcapacityinacrosssectionalpopulationofgermanchildren
AT laubsarah symptomssarscov2antibodiesandneutralizationcapacityinacrosssectionalpopulationofgermanchildren
AT schoberlpatricia symptomssarscov2antibodiesandneutralizationcapacityinacrosssectionalpopulationofgermanchildren
AT schweigerkabeschandrea symptomssarscov2antibodiesandneutralizationcapacityinacrosssectionalpopulationofgermanchildren
AT ewalddominik symptomssarscov2antibodiesandneutralizationcapacityinacrosssectionalpopulationofgermanchildren
AT hornmichael symptomssarscov2antibodiesandneutralizationcapacityinacrosssectionalpopulationofgermanchildren
AT niggeljakob symptomssarscov2antibodiesandneutralizationcapacityinacrosssectionalpopulationofgermanchildren
AT ambroschandreas symptomssarscov2antibodiesandneutralizationcapacityinacrosssectionalpopulationofgermanchildren
AT uberlaklaus symptomssarscov2antibodiesandneutralizationcapacityinacrosssectionalpopulationofgermanchildren
AT gerlingstephan symptomssarscov2antibodiesandneutralizationcapacityinacrosssectionalpopulationofgermanchildren
AT brandstettersusanne symptomssarscov2antibodiesandneutralizationcapacityinacrosssectionalpopulationofgermanchildren
AT wagnerralf symptomssarscov2antibodiesandneutralizationcapacityinacrosssectionalpopulationofgermanchildren
AT kabeschmichael symptomssarscov2antibodiesandneutralizationcapacityinacrosssectionalpopulationofgermanchildren
AT symptomssarscov2antibodiesandneutralizationcapacityinacrosssectionalpopulationofgermanchildren